Acousia Therapeutics GmbH
PrivateLast Round
VC Round
Jan 9, 2024
Total Funding Raised
$14.43M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Acousia Therapeutics GmbH is a biotechnology company that develops small molecule drugs for the treatment and prevention of sensorineural hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acousia Therapeutics GmbH Comparables
Compare Acousia Therapeutics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Audion Therapeutics | 86% | |
| AudioCure Pharma | 86% | |
| Platform Therapeutics, Inc. | 79% |
Acousia Therapeutics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 9, 2024 | ||||
| Series B | May 14, 2018 | ||||
| Series A | Dec 14, 2016 | ||||
| Seed | Sep 24, 2012 |
Acousia Therapeutics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Esperante Ventures | VC Round |
| Esperante | VC Round |
| Boehringer Ingelheim Venture Fund | Series B, Series A, Seed |
| Creathor Venture | Series B |
| KfW Development Bank | Series A, Series B |
| LBBW Venture Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 95% MoM.
- Apr 20, 2026
Monthly visitors grew 238% MoM, reaching 1.3K.
Acousia Therapeutics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Acousia Therapeutics GmbH's valuation, stock price, and market status.
Is Acousia Therapeutics GmbH a public or private company?
Acousia Therapeutics GmbH is a private company.
What is the current stock price of Acousia Therapeutics GmbH?
Acousia Therapeutics GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is Acousia Therapeutics GmbH worth (valuation)?
Valuation information for Acousia Therapeutics GmbH is not publicly available.
Can I buy Acousia Therapeutics GmbH stock?
Acousia Therapeutics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Acousia Therapeutics GmbH's last funding round?
Acousia Therapeutics GmbH's most recent funding round was VC Round on January 9, 2024.
Who are the main investors in Acousia Therapeutics GmbH?
Key investors in Acousia Therapeutics GmbH include Boehringer Ingelheim Venture Fund, LBBW Venture Capital.
Will Acousia Therapeutics GmbH IPO soon?
No public IPO plans have been announced for Acousia Therapeutics GmbH.
How can I track Acousia Therapeutics GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Acousia Therapeutics GmbH's secondary market activity and sign up for updates.